ABO Plasma was incorporated in October of 2020 with a singular focus of collecting medical-grade source blood plasma for our biotherapeutic pharmaceutical client base. Source plasma is used in the production of plasma protein-based injectable patient treatment therapies. Our mission is to provide a customer-focused donor experience while collecting source blood plasma to be utilized in the manufacturing of lifesaving therapies, improving the world we live in one donation at a time.